Wegener's granulomatosis: A challenging disease for otorhinolaryngologists

Acta Oto-Laryngologica

Volumn 125, Issue 10, 2005, Pages 1105-1110

  Cadoni, Gabriella ^a   Prelajade, Dalia ^b   Campobasso, Elena ^a   Calǒ, Lea ^a   Agostino, Stefania ^a   Manna, Raffaele ^a   Paludetti, Gaetano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Circulating antineutrophil cytoplasm antibodies; Cotrimoxazole; Cyclophosphamide; Methotrexate; Tumor necrosis factor inhibitors; Wegener's granulomatosis

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; FEMALE; HEAD AND NECK DISEASE; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; MALE; OTORHINOLARYNGOLOGY; PRIORITY JOURNAL; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; WEGENER GRANULOMATOSIS;

EID: 27144535373     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510028500     Document Type: Article

References (48)

1. Wegener F. Uber generalisierte, septische Gefasser-krankungen. Verh Dtsch Ges Pathol 1936;29:202-10.
2. Wegener F. Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol 1939;102:36-58.
3. Godman GC, Churg J. Wegener's granulomatosis. Pathology and review of the literature. Arch Pathol 1954;58:533-53.
4. Koldingsnes W, Nossent JC. Increasing incidence of Wegener's granulomatosis in a stable Caucasian population, during the 15 years period from 1984-1998 [abstract]. Arthritis Rheum 1984;42(Suppl):S318.
5. Hoffman GS, Kerr GS, Levitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: analysis of 158 patients. Ann Intern Med 1992;116:488-98.
6. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the 5-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
7. Bajema IM, Hagen EC, Van Der Woude FJ, Bruijn JA. Wegener's granulomatosis: meta-analysis of 349 literary case reports. J Lab Clin Med 1997;129:17-22.
8. Harper L, Cockwell P, Savage COS. Case of propylthiouracil-induced ANCA-associated small vessel vasculitis. Nephrol Dial Transplant 1998;13:455-8.
9. Schaffer JV, Davidson DM, McNiff JM, Bolognia JC. Perinuclear antineutrophil cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 2001;44:198-206.
10. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994;120:12-7.
11. Boudewyns A, Verbelen J, Koekelkoren E, Van Offel J, Van de Heyning P. Wegener's granulomatosis triggered by infection? Acta Otorhinolaryngol Belg 2001;55:57-63.
12. Hogan SL, Satterly KK, Dooley MA, Nackman PH, Jennette JC, Falk RJ. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001;12:134-42.
13. Harris A, Chang G, Vadas M, Gillis D. ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis. J Clin Pathol 1999;52:670-6.
14. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 2000;113:455-6.
15. Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplamic antibody testing. Curr Opin Rheumatol 2004;16:9-17.
16. Harper L, Savage COS. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000;190:349-59.
17. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in 18 patients and a review of the literature. Medicine (Baltimore) 1973;52:535-61.
18. McDonald TJ, De Remee RA. Wegener's granulomatosis. Laryngoscope 1993;93:220-31.
19. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
20. Langford CA. Wegener granulomatosis. Am J Med Sci 2001;321:76-82.
21. McDonald TJ, DeRemee RA, Kern EB, Harrison EG. Nasal manifestations of Wegener's granulomatosis. Laryngoscope 1974;84:2101-12.
22. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001;13:3-11.
23. Ilium P, Thorling K. Wegener's granulomatosis: longterm results of treatment. Ann Otol Rhinol Laryngol 1981; 90:231-4.
24. Kornblut AD, Wolff SM, Fauci AS. Ear disease in patients with Wegener's granulomatosis. Laryngoscope 1982;92:713-7.
25. Fauci AS, Haynes BF. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
26. Choufani G, Hassid S, Hernebert D. Otological manifestations of Wegener's granulomatosis. Acta Otorhinolaryngol Belg 1991;45:375-9 (in French).
27. Lebovics RS, Hoffman GS, Leavitt RY, Kerr GS, Travis WD, Kammerer W, et al. The management of subglottic stenosis in patients with Wegener's granulomatosis. Laryngoscope 1992;102:1341-5.
28. Almadori G, Trivelli M, Scarano E, Cadoni G. Misleading clinical features in Wegener's granulomatosis, A case report. J Laryngol Otol 1997;11:746-8.
29. Davenport A. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol 1992;37:124-30.
30. Macias JD, Wackym PA, McCabe BF. Early diagnosis of otologic Wegener's granulomatosis using the serologic marker cANCA. Ann Otol Rhinol Laryngol 1993;102:337-41.
31. Cadoni G, Agostino S, Campobasso E, Vulpiani P, Manna R, Galli J. Early diagnosis and stage-adapted treatment of Wegener's granulomatosis. J Laryngol Otol 2003;117:208-11.
32. Nischino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9.
33. De Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold-Keller E. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001;58:1215-21.
34. Laforgia A, Di Venere D, Poli M. Wegener's syndrome (or granulomatosis), A clinical case. Minerva Stomatol 1993; 42:547-52.
35. Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, et al. Wegener's granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993;122(1):26-31.
36. Gaughan RK, DeSanto LW, McDonald TJ. Use of anticytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis with subglottic stenosis. Laryngoscope 1990;100:561-3.
37. Matt BH. Wegener's granulomatosis, acute laryngotracheal obstruction and death in a 17 year old female: case report and review of the literature. Int J Pediatr Otorhinolaryngol 1996;37:163-72.
38. Cohen T, Huitema MG, Henè RJ, Sluiter WJ, The TH, Van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
39. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener's granulomatosis. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Society Research Committee. Q J Med 1992;302:427-38.
40. Bolley R, Mistry-Burchardi N, Samtleben W. Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up. Dtsch Med Wochenschr 2000;125:1519-25.
41. Carrie S, Hughes KB, Watson MG. Negative ANCA in Wegener's granulomatosis. J Laryngol Otol 1994;108:420-2.
42. Devaney KO, Ferlito A, Hunter BC, et al. Wegener's granulomatosis of the head and neck. Ann Otol Rhinol Laryngol 1998;107:439-45.
43. PausJenssen ES, Cockcroft DW. A case report of Wegener granulomatosis treated only with corticosteroids for 30 years. Ann Allergy Asthma Immunol 2003;91:82-5.
44. DeRemee RA. Wegener's granulomatosis. Curr Opin Pulm Med 1995;1:363-7.
45. Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis. Exp Opin Invest Drugs 2001;10:1279-89.
46. Frasca GM, Zoumparidis NG, Borgnino LC, Neri L, Vangelisti A, Bonomini V. Plasma exchange treatment in rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Int J Artif Organs 1992;15:181-4.
47. Fields CL, Ossario MA, Roy TM, Bunke CM. Wegener's granulomatosis complicated by pregnancy, A case report. J Reprod Med 1991;36:463-6.
48. Birck R, Warnatz K, Lorenz HM, Choi M, Haubitz M, Grunke M, et al. 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 2003;14:440-7.